These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

150 related articles for article (PubMed ID: 194476)

  • 21. Prophylaxis of varicella in children with neoplastic disease: comparative results with zoster immune plasma and gamma globulin.
    Geiser CF; Bishop Y; Myers M; Jaffe N; Yankee R
    Cancer; 1975 Apr; 35(4):1027-30. PubMed ID: 46775
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Live attenuated varicella vaccine use in immunocompromised children and adults.
    Gershon AA; Steinberg SP; Gelb L
    Pediatrics; 1986 Oct; 78(4 Pt 2):757-62. PubMed ID: 3020495
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Management of varicella-zoster contact and infection in pregnancy using a standardized varicella-zoster ELISA test.
    Enders G
    Postgrad Med J; 1985; 61 Suppl 4():23-30. PubMed ID: 3014475
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Varicella and herpes zoster: differences in antibody response revealed by the platelet aggregation technique.
    Palosuo T
    Scand J Infect Dis; 1972; 4(2):83-9. PubMed ID: 4341817
    [No Abstract]   [Full Text] [Related]  

  • 25. Molecular dissection of the humoral immune response to individual varicella-zoster viral proteins during chickenpox, quiescence, reinfection, and reactivation.
    Weigle KA; Grose C
    J Infect Dis; 1984 May; 149(5):741-9. PubMed ID: 6327848
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Low induction of varicella-zoster virus-specific secretory IgA antibody after vaccination.
    Terada K; Niizuma T; Yagi Y; Miyashima H; Kataoka N; Sadahiro T
    J Med Virol; 2000 Sep; 62(1):46-51. PubMed ID: 10935988
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Lack of transmission of the live attenuated varicella vaccine virus to immunocompromised children after immunization of their siblings.
    Diaz PS; Au D; Smith S; Amylon M; Link M; Smith S; Arvin AM
    Pediatrics; 1991 Feb; 87(2):166-70. PubMed ID: 1846236
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Incidence of serum antibody titers against varicella zoster virus in Japanese patients with herpes zoster.
    Miyachi M; Ihara H; Imafuku S
    J Dermatol; 2017 Jun; 44(6):656-659. PubMed ID: 28012212
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Prevention of varicella by zoster immune globulin.
    Brunell PA; Ross A; Miller LH; Kuo B
    N Engl J Med; 1969 May; 280(22):1191-4. PubMed ID: 4181206
    [No Abstract]   [Full Text] [Related]  

  • 30. Specific immunoglobulin responses after varicella and herpes zoster.
    Cradock-Watson JE; Ridehalgh MK; Bourne MS
    J Hyg (Lond); 1979 Apr; 82(2):319-36. PubMed ID: 219110
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Questions and controversies about varicella-zoster infections.
    Bialecki C; Feder HM
    Hosp Pract (Off Ed); 1989 Mar; 24(3A):21-2, 27, 31-2. PubMed ID: 2538487
    [No Abstract]   [Full Text] [Related]  

  • 32. Increased incidence of herpes zoster in normal children infected with varicella zoster virus during infancy: community-based follow-up study.
    Baba K; Yabuuchi H; Takahashi M; Ogra PL
    J Pediatr; 1986 Mar; 108(3):372-7. PubMed ID: 3005536
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Evaluation of varicella-zoster immune globulin: protection of immunosuppressed children after household exposure to varicella.
    Zaia JA; Levin MJ; Preblud SR; Leszczynski J; Wright GG; Ellis RJ; Curtis AC; Valerio MA; LeGore J
    J Infect Dis; 1983 Apr; 147(4):737-43. PubMed ID: 6341478
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [Acyclovir therapy in varicella/zoster diseases in immunocompromised children with cancer].
    Kuhn N; Landbeck G
    Monatsschr Kinderheilkd; 1984 Feb; 132(2):105-9. PubMed ID: 6328285
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Varicella vaccination: where do we go from here?
    Brunell PA
    Hosp Pract; 1980 Sep; 15(9):91-3, 97, 100-1 passim. PubMed ID: 6250972
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Perspectives on vaccines against varicella-zoster virus infections.
    Gershon AA; Gershon MD
    Curr Top Microbiol Immunol; 2010; 342():359-72. PubMed ID: 20232192
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Antibodies to the three major glycoproteins of varicella-zoster virus: search for the relevant host immune response.
    Brunell PA; Novelli VM; Keller PM; Ellis RW
    J Infect Dis; 1987 Sep; 156(3):430-5. PubMed ID: 3039010
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Transmission of varicella zoster virus from individuals with herpes zoster or varicella in school and day care settings.
    Viner K; Perella D; Lopez A; Bialek S; Newbern C; Pierre R; Spells N; Watson B
    J Infect Dis; 2012 May; 205(9):1336-41. PubMed ID: 22454467
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Radioimmunoassay for antibodies in varicella-zoster virus serology.
    Trlifajova J; Pokorný J; Nĕmecek V; Ryba M
    J Hyg Epidemiol Microbiol Immunol; 1979; 23(3):332-9. PubMed ID: 231068
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Relationship between serum anti-varicella zoster virus antibody titer and time from onset of herpes zoster.
    Ihara H; Miyachi M; Imafuku S
    J Dermatol; 2018 Feb; 45(2):189-193. PubMed ID: 29239011
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.